MetLife, Inc.
METNYSEFinancialsInsurance - Life
As of Oct 23, 2026 close
- Market cap
- $64.80B
- P/E (TTM)
- 18.26
- Forward P/E
- 23.15
- Dividend yield
- 2.24%
- 52-week range
- $67.33$102.43
- Volume (live)
- -
- Avg. volume (3M)
- 3.15M
MetLife (MET) Stock Price & Financial Analysis
MetLife Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $96.44 - $103.18 |
|---|---|
| 52-Week High | $102.43 |
| 52-Week Low | $67.33 |
| Open | $102.52 |
| Volume (last close) | 6.00M |
| Average Volume (3M) | 3.15M |
| Revenue (TTM) | 79.13B |
|---|---|
| Net Income (TTM) | 3.55B |
| Free Cash Flow (TTM) | 16.57B |
| EPS (TTM) | $5.36 |
| Profit Margin | 4.48% |
| Operating Margin | 6.15% |
| Return on Equity (ROE) | 12.98% |
| Debt to Equity | 0.74 |
| Annual Dividend | $2.32 |
|---|---|
| Dividend Yield | 2.24% |
| Payout Ratio | 43.25% |
| Next Dividend Ex-Date | Nov 3, 2026 |
| Market Cap | 64.80B |
|---|---|
| Shares Outstanding | 655.70M |
| P/E Ratio (TTM) | 18.26 |
| Forward P/E | 23.15 |
| Price to Sales (P/S) | 0.82 |
| Price to Book (P/B) | 2.37 |
| EV/EBITDA | 11.44 |
| 50-Day MA | $96.99 |
|---|---|
| 200-Day MA | $84.84 |
| 1-Year Change | +32.49% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
MetLife at a Glance
As of the Oct 23, 2026 close, MetLife (MET) has a market capitalization of $64.80B. The stock trades at 18.3× trailing earnings, 23.1× forward earnings and 0.8× sales. Over the trailing twelve months it earned $3.55B on revenue of $79.13B (a 4.5% profit margin) and generated $16.57B of free cash flow. Revenue grew 8.5% year over year.
As of its latest reported balance sheet, it holds $22.69B in cash and securities against $20.29B of debt, a net cash position of $2.40B.
MetLife pays a quarterly dividend totaling $2.32 per share a year, a 2.24% yield at the Oct 23, 2026 close, with a 43% payout ratio and 13 consecutive years of dividend increases.
The share price is up 32.5% over the past year. At $98.82 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $67.33 to $102.42, above its 200-day moving average of $84.84.
Based on 16 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $111.55, 12.9% above the Oct 23, 2026 close.
Frequently Asked Questions About MetLife
What is the current stock price for MET?
As of the Oct 23, 2026 close, MET stock trades at $98.82. The 52-week range is $67.33–$102.43, with a day range of $96.44–$103.18.
What is the P/E ratio for MET?
As of the Oct 23, 2026 close, MetLife's trailing twelve-month (TTM) P/E ratio is 18.3, meaning investors pay $18.3 for every $1 of annual earnings. The forward P/E is 23.1, reflecting analyst expectations for future earnings. MetLife operates in the Financials sector.
Does MET pay dividends?
Yes, MetLife pays a 2.24% annual dividend yield as of the Oct 23, 2026 close ($2.32 per share a year). The trailing twelve-month payout ratio is 43.3%. The next ex-dividend date is November 3, 2026.
What do analysts recommend for MET?
Based on ratings from 16 professional analysts over the last 90 days, the consensus for MET is Buy. The average 12-month price target is $111.55, a 12.9% upside from the Oct 23, 2026 close of $98.82.
What is the market cap of MET?
As of the Oct 23, 2026 close, MetLife's market capitalization is $64.80B, classifying it as a large-cap company. MetLife operates in the Financials sector within the Insurance - Life industry.